Clinical Trial Update: Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial [Phase 3]

View source ↗

Summary

Phase 3 trial of autologous stem cell systemic sclerosis immune suppression has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Snippet

Sponsor: Northwestern University | Conditions: Scleroderma, Systemic | Phase 3 | Status: TERMINATED | Results posted: 2020-07-23